For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Atopic Dermatitis Study (48 Weeks)
Study Summary
Who Can Participate?
Adults aged ≥ 18 years with moderate to severe AD may participate.
Inclusion Criteria
-
-
- have AD involvement of ≥ 10% body surface area (BSA)*
- AD diagnosis confirmed by a dermatologist according to the Hanifin/Rajka criteria >=1year prior to SCN
- documented history (<=12mo of SCN) of inadequate response to topical corticosteroids (TCS) or topical calcineurin inhibitors (TCI)
- no past or current use of dupilumab or any systemic or topical JAK inhibitors
-
* 1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers).
Participant Information
-
-
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating atopic dermatitis (up to 16 visits)
- Will receive an investigative subcutaneous treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
-
How Long Will the Study Last?
48 weeks
For more information about this trial, please visit ClinicalTrials.gov
